LILRB2 and neoplasm: Tumor‐derived immunoglobulin‐like transcript 4 (ILT4) and PIR‐B (ILT4 homolog) induce effector T cell senescence by activating the MAPK ERK1/2 signaling pathway to increase fatty acid synthesis and lipid accumulation in tumor cells, increased the survival in patients with ICI treatment.194